Advanced search
Publication Cover
OncoImmunology Volume 12, 2023 - Issue 1
Submit an article Journal homepage
2,140
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic

Maite Alvareza Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5969-9181View further author information
ORCID Icon,
Carmen Molinaa Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, SpainView further author information
,
Saray Garasaa Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, SpainView further author information
,
Maria C. Ochoaa Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, SpainView further author information
,
Maria E Rodriguez-Ruizd Departments of Immunology and Oncology (CCUN), Clínica Universidad de Navarra, Pamplona, SpainView further author information
,
Gabriel Gomisa Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, SpainView further author information
,
Assunta Cirellaa Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, SpainView further author information
,
Irene Oliveraa Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, SpainView further author information
,
Javier Glez-Vaza Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, SpainView further author information
,
Jose Gonzalez-Gomariza Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, SpainView further author information
,
carlos luri-Reya Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, SpainView further author information
,
arantza azpilikuetaa Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, SpainView further author information
,
Elixabet Bolañosa Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, SpainView further author information
,
Alvaro Teijeiraa Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, SpainView further author information
,
Pedro Berraondoa Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, SpainView further author information
,
Marisol Quinteroe Highlight Therapeutics, Valencia, SpainView further author information
&
Ignacio Meleroa Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain;b Navarra Institute for Health Research (IdiSNA), Pamplona, Spain;c Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain;d Departments of Immunology and Oncology (CCUN), Clínica Universidad de Navarra, Pamplona, Spain;f Nuffield Department of Medicine and Oxford Center for Immuno-Oncology, University of Oxford, Oxford, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1360-348XView further author information
ORCID Icon show all
Article: 2197370 | Received 06 Mar 2023, Accepted 27 Mar 2023, Published online: 05 Apr 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.